We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
LIDOCAINE (Phebra Pty Ltd)
Product name
LIDOCAINE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
136 (255 working days)
Active ingredients
adrenaline (epinephrine) acid tartrate, lidocaine hydrochloride monohydrate
Registration type
New generic medicine
Indication
LIDOCAINE WITH ADRENALINE PHEBRA is indicated for the production of local or regional anaesthesia by the following techniques:
- infiltration,
- peripheral nerve block such as intercostal block,
- major plexus block such as brachial plexus block,
- epidural block,
- subarachnoid block.